BIOSYNTHESIS OF RNAS

RNAS的生物合成

基本信息

项目摘要

Our long-term objectives are to exploit the powerful techniques available in the yeast Saccharymocyes cerevisiae for an understanding of messenger RNA splicing at the molecular level. Our future work relies on our recent demonstration of a 1:1 correspondence between five small nuclear RNAs (snRNAs) in this yeast and mammalian structural organization. One focus of your program -- motivated by the discovery of group II self-splicing RNAs - - will be to seek catalytic roles for these snRNAs. We will identify those residues that are the best candidates for such functions using a combined genetic, phylogenetic, and biochemical approach. First, structural domains inferred from phylogenetic comparisons will be deleted and assayed by complementation of deletion strains. When an essential domain is identified, its function will be further assessed by inter-species "swaps"; this provides a rapid and rational method of bulk mutagenesis. Finally, evolutionarily invariant nucleotides in these chimeras will by subjected to site-specific mutagenesis, to identify change which lead to lethal or, ideally, conditionally lethal phenotypes. To determine the specific functional lesion, we will assay the pattern of splicing intermediates in vivo, and the distribution of spliceosomal complexes within the ordered assembly pathway in vitro. The complementary focus of this project is to understand what roles the spliceosomal proteins play, many of which are known to be essential for viability. We will explore the hypothesis that at least certain of these proteins participate in proofreading functions, consistent with the large number of steps in the spliceosome assembly pathway that require ATP. In particular, we have cloned and sequenced a nucleotide; rna16-1 has a consensus ATP binding site and other features of a recently reported superfamily, members of which include EIF4alpha and a protein required for mitochondrial mRNA splicing. We propose genetic and biochemical tests of the model that RNA16 functions in branchpoint recognition to effect an ATP- dependent conformational switch; by this view, rna16-1 is a "clock mutant" that acts as a suppressor by decreasing the time allowed for incorrect splicing substrates to dissociate. This model has important consequences for elucidating the molecular mechanisms used to maintain biologically tolerable error rates in complex macromolecular precesses.
我们的长期目标是利用现有的强大技术

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CHRISTINE GUTHRIE其他文献

CHRISTINE GUTHRIE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CHRISTINE GUTHRIE', 18)}}的其他基金

Biosynthesis of RNAs
RNA的生物合成
  • 批准号:
    7904471
  • 财政年份:
    2009
  • 资助金额:
    $ 52.12万
  • 项目类别:
ANALYSIS OF SPLICEOSOMAL COMPLEXES
剪接体复合物的分析
  • 批准号:
    7182397
  • 财政年份:
    2005
  • 资助金额:
    $ 52.12万
  • 项目类别:
SEARCHING FOR INTERACTORS WITH THE RNA HELICASE SUB2
寻找与 RNA 解旋酶 SUB2 相互作用的蛋白
  • 批准号:
    6979588
  • 财政年份:
    2004
  • 资助金额:
    $ 52.12万
  • 项目类别:
BIOSYNTHESIS OF RNAS
RNAS的生物合成
  • 批准号:
    2173652
  • 财政年份:
    1977
  • 资助金额:
    $ 52.12万
  • 项目类别:
BIOSYNTHESIS OF RNAS
RNAS的生物合成
  • 批准号:
    3270256
  • 财政年份:
    1977
  • 资助金额:
    $ 52.12万
  • 项目类别:
Biosynthesis of RNAs
RNA的生物合成
  • 批准号:
    7033075
  • 财政年份:
    1977
  • 资助金额:
    $ 52.12万
  • 项目类别:
Biosynthesis of RNAs
RNA的生物合成
  • 批准号:
    8055302
  • 财政年份:
    1977
  • 资助金额:
    $ 52.12万
  • 项目类别:
BIOSYNTHESIS OF RNAS
RNAS的生物合成
  • 批准号:
    2173650
  • 财政年份:
    1977
  • 资助金额:
    $ 52.12万
  • 项目类别:
BIOSYNTHESIS OF RNAS
RNAS的生物合成
  • 批准号:
    2872641
  • 财政年份:
    1977
  • 资助金额:
    $ 52.12万
  • 项目类别:
BIOSYNTHESIS OF RNAS
RNAS的生物合成
  • 批准号:
    3484389
  • 财政年份:
    1977
  • 资助金额:
    $ 52.12万
  • 项目类别:

相似海外基金

Mechanisms of messenger RNA splicing and RNA processing regulation
信使RNA剪接和RNA加工调控机制
  • 批准号:
    10623834
  • 财政年份:
    2023
  • 资助金额:
    $ 52.12万
  • 项目类别:
Collaborative Research: Connecting the sequence logic of RNA splicing to nuclear localization
合作研究:将 RNA 剪接的序列逻辑与核定位联系起来
  • 批准号:
    2246530
  • 财政年份:
    2023
  • 资助金额:
    $ 52.12万
  • 项目类别:
    Standard Grant
Collaborative Research: Connecting the sequence logic of RNA splicing to nuclear localization
合作研究:将 RNA 剪接的序列逻辑与核定位联系起来
  • 批准号:
    2246531
  • 财政年份:
    2023
  • 资助金额:
    $ 52.12万
  • 项目类别:
    Standard Grant
Analysis on how RNA splicing factors change global gene expression patterns and regulate male fertility.
分析RNA剪接因子如何改变全局基因表达模式并调节男性生育能力。
  • 批准号:
    2882792
  • 财政年份:
    2023
  • 资助金额:
    $ 52.12万
  • 项目类别:
    Studentship
Aberrant RNA splicing in sporadic inclusion body myositis
散发性包涵体肌炎中的异常RNA剪接
  • 批准号:
    23K18260
  • 财政年份:
    2023
  • 资助金额:
    $ 52.12万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Synthetic introns for selective targeting of RNA splicing factor-mutant leukemia
用于选择性靶向RNA剪接因子突变型白血病的合成内含子
  • 批准号:
    10722782
  • 财政年份:
    2023
  • 资助金额:
    $ 52.12万
  • 项目类别:
Cancer immune therapeutics targeting aberrant RNA splicing products
针对异常 RNA 剪接产物的癌症免疫疗法
  • 批准号:
    23H02688
  • 财政年份:
    2023
  • 资助金额:
    $ 52.12万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
RNA splicing regulation during alcohol withdrawal
酒精戒断过程中的 RNA 剪接调节
  • 批准号:
    10785159
  • 财政年份:
    2023
  • 资助金额:
    $ 52.12万
  • 项目类别:
Targeting Dysregulated RNA Splicing in Neurodegenerative Diseases
靶向神经退行性疾病中失调的 RNA 剪接
  • 批准号:
    10729566
  • 财政年份:
    2023
  • 资助金额:
    $ 52.12万
  • 项目类别:
Srsf3-mediated alternative RNA splicing in craniofacial development
Srsf3介导的颅面发育中的选择性RNA剪接
  • 批准号:
    10650417
  • 财政年份:
    2022
  • 资助金额:
    $ 52.12万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了